SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000921895-17-002976
Filing Date
2017-12-29
Accepted
2017-12-29 16:44:03
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d09271023_12292017.htm SC 13D 141938
2 JOINT FILING AND SOLICITATION AGREEMENT ex991to13d09271023_122917.htm EX-99.1 26527
  Complete submission text file 0000921895-17-002976.txt   170348
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Aviragen Therapeutics, Inc. (Subject) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13D | Act: 34 | File No.: 005-31596 | Film No.: 171282426
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 13100 GREGG STREET SUITE A POWAY CA 92064
Business Address 1048 INDUSTRIAL COURT SUWANEE GA 30024 (858) 726-1600
DIGIRAD CORP (Filed by) CIK: 0000707388 (see all company filings)

IRS No.: 330145723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 3845 Electromedical & Electrotherapeutic Apparatus